Skip to content

BBNX BBNX Gross margin

Gross margin at other companies

Insulet logo
InsuletPODD
71%+0.6pp
Tandem Diabetes Care logo
Tandem Diabetes CareTNDM
54.9%+2.7pp
Medtronic logo
MedtronicMDT
65%-0.3pp
AdaptHealth logo
AdaptHealthAHCO
18.3%-1.6pp
Halozyme Therapeutics logo
Halozyme TherapeuticsHALO
82.8%-0.7pp

Other financials

Income statement

See full
Revenue$27.6M+56.6%
Gross profit$16.4M+83.2%
Operating income-$24.3M-30.2%
Net income-$21.9M+23.6%
EPS (diluted)-$0.49+47.3%

Balance sheet

See full
Cash & equivalents$30.2M-28.9%
Total debt$6.9M-0.9%
Total equity$271.2M-13.5%
Total assets$304.4M-9.9%

Cash flow

See full
Operating cash flow-$23.8M-19.3%
CapEx$1.4M+314%
Free cash flow-$25.2M-24.1%

Valuation

See full
Market cap$708.98M-8.6%
Enterprise value$685.68M
P/S6.4×

Profitability

See full
Operating margin-70.1%-6.4pp
Net margin-60.3%-17.4pp
FCF margin-55.4%-14.3pp

Returns & leverage

See full
Return on equity-22.7%
Debt / equity0.0×
Current ratio10.7×-5.2×

Where this comes from

Calculated from BBNX’s reported figures.

Based on trailing twelve months.

The official record: BBNX’s 10-Q, filed April 21, 2026, on SEC EDGAR. View the filing →

Ask your AI about BBNX's gross margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BBNX's gross margin?
BBNX (BBNX) reported gross margin of 57.2% in Q1 2026.
How has BBNX's gross margin changed year-over-year?
BBNX's gross margin increased by 6.0% year-over-year, from 53.9% to 57.2%.
What is the long-term trend for BBNX's gross margin?
Over 2 years (2023 to 2025), BBNX's gross margin has grown at a 2.6% compound annual growth rate (CAGR), from 52.6% to 55.4%.
What does gross margin mean?
Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.